首页 > 最新文献

BMJ : British Medical Journal最新文献

英文 中文
Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial. 提供膝关节支架治疗膝关节骨性关节炎(PROP OA):多中心,平行组,优势,统计学家盲法,随机对照试验。
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-26 DOI: 10.1136/bmj-2025-086005
Melanie A Holden, Elaine Nicholls, Zainab Abdali, Fraser Birrell, Belinda Borrelli, Michael Callaghan, Krysia Dziedzic, David Felson, Nadine E Foster, Nicola Halliday, Carol Ingram, Clare Jinks, Sue Jowett, George Peat

Objective: To determine whether adding compartment specific knee bracing with an adherence intervention to advice, written information, and exercise instruction (AIE+B) is superior to advice, written information, and exercise instruction (AIE) only in improving patient reported outcomes in people with knee osteoarthritis.

Design: Multicentre, parallel group, superiority, statistician blinded, randomised (1:1; block; stratified; centralised web based) controlled trial.

Setting: Recruitment through general practices and the community in Cheshire, Manchester, North Tyneside, and Staffordshire, England; enrolment 25 November 2019 to 16 September 2022.

Participants: 466 adults aged ≥45 years with symptoms of knee osteoarthritis.

Interventions: AIE was delivered in one in-person consultation by a trained physiotherapist. Individuals randomised to the AIE+B group were also fitted with a patellofemoral, tibiofemoral unloading, or neutral stabilising knee brace, according to their predominant compartmental distribution of knee osteoarthritis, and were offered a two week follow-up consultation. Brief motivational interviewing with targeted text reminders supported brace adherence.

Main outcome measures: The primary outcome was a composite patient reported Knee Osteoarthritis Outcomes Score (KOOS)-5 (0-100) at six months after randomisation. Key secondary outcomes were KOOS-5 at three and 12 months, KOOS-5 subscale scores, and pain on weight bearing activity at three, six, and 12 months.

Results: 466 participants (mean age 64 (standard deviation 9) years; 46% female participants) were randomised, with 401 (86%), 394 (85%), and 370 (79%) participants followed up with analysable data at three, six, and 12 months, respectively. At six months, greater improvement in KOOS-5 was seen in the AIE+B group than in the AIE group (adjusted mean difference 3.39, 95% confidence interval (CI) 0.96 to 5.82; effect size 0.24). Secondary outcomes showed the benefits of AIE+B over AIE that diminished over time. The largest effects observed were for pain reduction (KOOS pain (0-100) adjusted mean difference at six months 6.13, 95% CI 3.36 to 8.91; effect size 0.39). Adverse events were minor and expected.

Conclusions: Adding compartment specific knee bracing and an adherence intervention to advice, written information, and exercise instruction resulted in small improvements in patient reported outcomes among individuals with knee osteoarthritis. This safe intervention offers a potential treatment option for this common condition.

Trial registration: ISRCTN28555470.

目的:确定在改善膝骨性关节炎患者报告的预后方面,在建议、书面信息和运动指导(AIE+B)的依从性干预下添加室特异性膝关节支具是否优于建议、书面信息和运动指导(AIE)。设计:多中心,平行组,优势,统计学家盲法,随机(1:1,区域,分层,基于集中网络)对照试验。环境:通过柴郡、曼彻斯特、北泰恩赛德和英格兰斯塔福德郡的一般做法和社区招聘;2019年11月25日至2022年9月16日。参与者:466名年龄≥45岁且有膝骨关节炎症状的成年人。干预措施:AIE由一位训练有素的物理治疗师进行一次面对面的咨询。随机分配到AIE+B组的个体也根据其主要的膝关节骨关节炎的腔室分布,安装髌骨、胫股卸载或中性稳定膝支具,并提供两周的随访咨询。简短的动机访谈与目标文本提醒支持支撑坚持。主要结局指标:主要结局是在随机分组后6个月报告膝关节骨关节炎结局评分(kos)-5(0-100)的复合患者。关键的次要结局是3个月和12个月时的KOOS-5, KOOS-5亚量表评分,以及3个月、6个月和12个月时的负重活动疼痛。结果:466名参与者(平均年龄64岁(标准差9)岁;46%的女性参与者)被随机分配,分别有401(86%)、394(85%)和370(79%)名参与者在3个月、6个月和12个月的可分析数据随访。6个月时,AIE+B组的KOOS-5改善程度高于AIE组(调整后平均差值3.39,95%可信区间(CI) 0.96 ~ 5.82;效应值0.24)。次要结果显示AIE+B优于AIE的益处随着时间的推移而减弱。观察到的最大效果是疼痛减轻(kos疼痛(0-100))6个月调整后的平均差异为6.13,95% CI为3.36至8.91;效应值0.39)。不良事件轻微且在意料之中。结论:在膝骨关节炎患者报告的结果中,在建议、书面信息和运动指导中加入特定腔室的膝关节支撑和依从性干预,导致患者报告的结果略有改善。这种安全的干预措施为这种常见疾病提供了一种潜在的治疗选择。试验注册:ISRCTN28555470。
{"title":"Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.","authors":"Melanie A Holden, Elaine Nicholls, Zainab Abdali, Fraser Birrell, Belinda Borrelli, Michael Callaghan, Krysia Dziedzic, David Felson, Nadine E Foster, Nicola Halliday, Carol Ingram, Clare Jinks, Sue Jowett, George Peat","doi":"10.1136/bmj-2025-086005","DOIUrl":"10.1136/bmj-2025-086005","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether adding compartment specific knee bracing with an adherence intervention to advice, written information, and exercise instruction (AIE+B) is superior to advice, written information, and exercise instruction (AIE) only in improving patient reported outcomes in people with knee osteoarthritis.</p><p><strong>Design: </strong>Multicentre, parallel group, superiority, statistician blinded, randomised (1:1; block; stratified; centralised web based) controlled trial.</p><p><strong>Setting: </strong>Recruitment through general practices and the community in Cheshire, Manchester, North Tyneside, and Staffordshire, England; enrolment 25 November 2019 to 16 September 2022.</p><p><strong>Participants: </strong>466 adults aged ≥45 years with symptoms of knee osteoarthritis.</p><p><strong>Interventions: </strong>AIE was delivered in one in-person consultation by a trained physiotherapist. Individuals randomised to the AIE+B group were also fitted with a patellofemoral, tibiofemoral unloading, or neutral stabilising knee brace, according to their predominant compartmental distribution of knee osteoarthritis, and were offered a two week follow-up consultation. Brief motivational interviewing with targeted text reminders supported brace adherence.</p><p><strong>Main outcome measures: </strong>The primary outcome was a composite patient reported Knee Osteoarthritis Outcomes Score (KOOS)-5 (0-100) at six months after randomisation. Key secondary outcomes were KOOS-5 at three and 12 months, KOOS-5 subscale scores, and pain on weight bearing activity at three, six, and 12 months.</p><p><strong>Results: </strong>466 participants (mean age 64 (standard deviation 9) years; 46% female participants) were randomised, with 401 (86%), 394 (85%), and 370 (79%) participants followed up with analysable data at three, six, and 12 months, respectively. At six months, greater improvement in KOOS-5 was seen in the AIE+B group than in the AIE group (adjusted mean difference 3.39, 95% confidence interval (CI) 0.96 to 5.82; effect size 0.24). Secondary outcomes showed the benefits of AIE+B over AIE that diminished over time. The largest effects observed were for pain reduction (KOOS pain (0-100) adjusted mean difference at six months 6.13, 95% CI 3.36 to 8.91; effect size 0.39). Adverse events were minor and expected.</p><p><strong>Conclusions: </strong>Adding compartment specific knee bracing and an adherence intervention to advice, written information, and exercise instruction resulted in small improvements in patient reported outcomes among individuals with knee osteoarthritis. This safe intervention offers a potential treatment option for this common condition.</p><p><strong>Trial registration: </strong>ISRCTN28555470.</p>","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"e086005"},"PeriodicalIF":42.7,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12829467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146050496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controversial African vaccine trial likened to Tuskegee is "cancelled"-but US funders insist it will continue. 被比作塔斯基吉的有争议的非洲疫苗试验被“取消”——但美国资助者坚称它将继续进行。
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-26 DOI: 10.1136/bmj.s161
Owen Dyer
{"title":"Controversial African vaccine trial likened to Tuskegee is \"cancelled\"-but US funders insist it will continue.","authors":"Owen Dyer","doi":"10.1136/bmj.s161","DOIUrl":"https://doi.org/10.1136/bmj.s161","url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"s161"},"PeriodicalIF":42.7,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146050417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formula milk: Experts demand tighter safety checks after contamination scare. 配方奶粉:污染恐慌后专家要求加强安全检查。
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-26 DOI: 10.1136/bmj.s164
Gareth Iacobucci
{"title":"Formula milk: Experts demand tighter safety checks after contamination scare.","authors":"Gareth Iacobucci","doi":"10.1136/bmj.s164","DOIUrl":"https://doi.org/10.1136/bmj.s164","url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"s164"},"PeriodicalIF":42.7,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146050428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incentives for increasing blood donations. 增加献血的激励措施。
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-21 DOI: 10.1136/bmj.s100
Stéphane Sanchez, Véronique Gangand, Jan Chrusciel
{"title":"Incentives for increasing blood donations.","authors":"Stéphane Sanchez, Véronique Gangand, Jan Chrusciel","doi":"10.1136/bmj.s100","DOIUrl":"https://doi.org/10.1136/bmj.s100","url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"s100"},"PeriodicalIF":42.7,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146017405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse effects of proton pump inhibitors. 质子泵抑制剂的不良反应。
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-21 DOI: 10.1136/bmj.s95
Wade Thompson, Anton Pottegård
{"title":"Adverse effects of proton pump inhibitors.","authors":"Wade Thompson, Anton Pottegård","doi":"10.1136/bmj.s95","DOIUrl":"https://doi.org/10.1136/bmj.s95","url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"s95"},"PeriodicalIF":42.7,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146017458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helen Salisbury: Whole system thinking. 海伦·索尔兹伯里:全系统思考。
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-20 DOI: 10.1136/bmj.s117
Helen Salisbury
{"title":"Helen Salisbury: Whole system thinking.","authors":"Helen Salisbury","doi":"10.1136/bmj.s117","DOIUrl":"https://doi.org/10.1136/bmj.s117","url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"s117"},"PeriodicalIF":42.7,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146009001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The BMJ appeal 2025-26: How innovation is supporting those who need it most. 《英国医学杂志2025-26》呼吁:创新如何支持最需要创新的人。
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-20 DOI: 10.1136/bmj.s97
{"title":"The BMJ appeal 2025-26: How innovation is supporting those who need it most.","authors":"","doi":"10.1136/bmj.s97","DOIUrl":"https://doi.org/10.1136/bmj.s97","url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"s97"},"PeriodicalIF":42.7,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146008966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CORRECTION: Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes: natural experiment study. 更正:怀孕后1000天摄入糖配给和长期心血管结果:自然实验研究。
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-20 DOI: 10.1136/bmj.s119
{"title":"CORRECTION: Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes: natural experiment study.","authors":"","doi":"10.1136/bmj.s119","DOIUrl":"10.1136/bmj.s119","url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"s119"},"PeriodicalIF":42.7,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12818181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146008917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is "triple strength" Wegovy, and why has the MHRA approved it? 什么是“三重强度”Wegovy,为什么MHRA批准了它?
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-19 DOI: 10.1136/bmj.s111
Katharine Lang
{"title":"What is \"triple strength\" Wegovy, and why has the MHRA approved it?","authors":"Katharine Lang","doi":"10.1136/bmj.s111","DOIUrl":"https://doi.org/10.1136/bmj.s111","url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"s111"},"PeriodicalIF":42.7,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146002814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"I want my students to feel supported"-the foundation doctor taking time out of training to teach. “我想让我的学生感到被支持”——基金会博士从培训中抽出时间来教书。
IF 42.7 1区 医学 Q1 Medicine Pub Date : 2026-01-19 DOI: 10.1136/bmj.s15
Erin Dean
{"title":"\"I want my students to feel supported\"-the foundation doctor taking time out of training to teach.","authors":"Erin Dean","doi":"10.1136/bmj.s15","DOIUrl":"https://doi.org/10.1136/bmj.s15","url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"392 ","pages":"s15"},"PeriodicalIF":42.7,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146002823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMJ : British Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1